Finance
Results: 169-180 of 44322

Miami International Holdings Announces Date of Second Quarter 2026 Earnings Release and Conference Call

Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation







